Skip to content

Utah Medical Products UTMD Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin57.1%-1.9pp59%-0.8pp59.8%-1.8pp61.6%-1.4pp
Operating margin29.6%-3.6pp33.2%-0.2pp33.4%-4.4pp37.9%-0.6pp
Net margin29.3%-4.6pp33.9%+0.8pp33.1%+1.6pp31.5%+1.4pp
Returns
Return on equity9.5%-1.8pp11.3%-2.4pp13.7%-1.2pp14.9%+0.8pp
Return on invested capital26.5%-5.3pp31.8%-4.9pp36.7%+0.1pp36.6%+6.8pp
Efficiency
Asset turnover0.3×0.0×0.3×-0.1×0.4×0.0×0.4×0.0×
Liquidity
Current ratio37.6×+12.0×25.6×+3.1×22.6×+7.5×15.1×-4.4×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×
Net debt / EBITDA-6×-0.9×-5×-1.0×-4×-1.2×-2.8×-0.5×
Per Share
Book value per share$36.81+9.8%$33.52-5.0%$35.28+12.5%$31.36+7.1%
Valuation
Market capitalization$219.63M+26.4%$208.48M-31.8%$305.63M-16.2%$364.68M-0.1%
Price / earnings20.3×+6.4×15×-3.3×18.4×-3.8×22.1×-2.6×
Price / sales5.9×+1.4×5.1×-1.0×6.1×-0.9×-0.5×
Price / book1.9×+0.4×1.8×-0.6×2.4×-0.8×3.2×-0.2×
EV / EBITDA10.5×+4.0×7.7×-1.5×9.2×-1.6×10.8×-0.8×
Dividend yield1.7%-0.5pp2%+0.6pp1.4%+0.5pp0.9%-2.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Utah Medical Products's profit margins?
Utah Medical Products (UTMD) runs a 57.9% gross margin and a 28.8% operating margin, with a 28.9% net margin.
Where do Utah Medical Products's ratios come from?
Every ratio is computed from Utah Medical Products's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.